Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987350 · ClinicalTrials.gov registry record · Phase 4
Safety Study of Seasonal Influenza Vaccine by Jet Injection
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00987350 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 60 participants.
The verdict
NCT00987350, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This research study involves testing of a device that can give injections (shots) without the use of a needle.
Interventions
- DEVICE LectraJet
- DEVICE TIV by jet injection
- BIOLOGICAL Seasonal Trivalent Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00987350
The ClinicalTrials.gov registry entry for NCT00987350 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which LectraJet is the first listed.
NCT00987350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00987350 about?
NCT00987350 is a clinical study titled "Safety Study of Seasonal Influenza Vaccine by Jet Injection". This research study involves testing of a device that can give injections (shots) without the use of a needle.
What is the current status of trial NCT00987350?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2010-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00987350?
The interventions under investigation include: LectraJet (DEVICE), TIV by jet injection (DEVICE), Seasonal Trivalent Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00987350?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.